Cwbio Overview
- Status
-
Public
- Employees
-
769
- Stock Symbol
-
688426
- Share Price
-
$2.71
- (As of Friday Closing)
Cwbio General Information
Description
Jiangsu Cowin Biotech Co Ltd is a national high-tech enterprise with independent intellectual property rights based in the field of life sciences. It provides innovative biological products and services to in vitro diagnostic users. The product line mainly includes molecular diagnostic raw materials enzymes, nucleic acid collection and protection agents, nucleic acid extraction kits, molecular diagnostic detection reagents and others.
Contact Information
Website
www.cwbio.comCorporate Office
- Number 18, Zelan Road
- Taizhou Medical High-tech Zone
- Taizhou, Jiangsu 225311
- China
Corporate Office
- Number 18, Zelan Road
- Taizhou Medical High-tech Zone
- Taizhou, Jiangsu 225311
- China
Cwbio Stock Performance
As of 13-Nov-2026, Cwbio’s stock price is $2.71. Its current market cap is $305M with 112M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.71 | $2.81 | $2.13 - $4.74 | $305M | 112M | 1.99M | -$0.11 |
Cwbio Financials Summary
As of 30-Sep-2026, Cwbio has a trailing 12-month revenue of $33.7M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 273,605 | 301,654 | 358,156 | 315,775 |
| Revenue | 33,665 | 26,910 | 17,542 | 24,218 |
| EBITDA | (11,488) | (10,077) | (18,162) | (9,734) |
| Net Income | (11,908) | (14,936) | (21,909) | (11,931) |
| Total Assets | 219,102 | 213,924 | 221,659 | 257,063 |
| Total Debt | 6,002 | 2,066 | 3,814 | 4,649 |
Cwbio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cwbio Patents
Cwbio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10975418-B1 | Rapid pcr-based virus detection method, and kits therefor | Active | 29-Jun-2020 | ||
| WO-2022000152-A1 | Rapid pcr-based virus detection method, and kits therefor | Inactive | 29-Jun-2020 |
Cwbio Signals
Cwbio ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Cwbio FAQs
-
Where is Cwbio headquartered?
Cwbio is headquartered in Taizhou, China.
-
What is the size of Cwbio?
Cwbio has 769 total employees.
-
What industry is Cwbio in?
Cwbio’s primary industry is Biotechnology.
-
Is Cwbio a private or public company?
Cwbio is a Public company.
-
What is Cwbio’s stock symbol?
The ticker symbol for Cwbio is 688426.
-
What is the current stock price of Cwbio?
As of 13-Nov-2026 the stock price of Cwbio is $2.71.
-
What is the current market cap of Cwbio?
The current market capitalization of Cwbio is $305M.
-
What is Cwbio’s current revenue?
The trailing twelve month revenue for Cwbio is $33.7M.
-
What is Cwbio’s annual earnings per share (EPS)?
Cwbio’s EPS for 12 months was -$0.11.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process